My wife, Kris said, "Whatcha doin today?"
I said, "Nothing."
Kris said, "You did that yesterday."
I said, "I wasn't finished."
Provided by Darlene, In Pembroke Pines, Fl.
In the 1970s, Gordon E. Moore theorized that computer processing power doubles about every 18 months especially relative to cost or size. His theory, known as Moore’s Law, has proved largely true. Thinner, sleeker, and faster computers have replaced the big boxes and monitors people once owned 10 years ago.
This phenomenon is not limited to computers. Each day, various types of consumer electronics are constantly being upgraded or completely scrapped in favor of technological advancements. In the process, scores of old VCRs, walkman cassette decks and bulky video cameras become what is known as “e-waste” or electronic waste.
Americans have amassed an enormous amount of electronic devices—an estimated three billion in total. Given the large amount of potential products involved, e-waste includes a broad range of electronic devices. Unfortunately, improper disposal of e-waste creates a significant burden on landfills because toxic substances can leach into the soil and groundwater. Absent recycling, the problem could escalate.
The total annual global volume of e-waste is expected to reach about 40 million metric tons. In the U.S. alone, it is estimated that we generated 1.5 billion pounds of all kinds of e-waste in 2006. This includes an estimated 44 million computers and televisions.
This amount is likely to increase because e-waste is growing at three times the rate of other municipal waste. Although e-waste accounts for only one to four percent of municipal waste, it may be responsible for as much as 70 percent of the heavy metals in landfills, including 40 percent of all lead.
Certain items are particularly harmful. For instance, CRT-based computer and television monitors contain on average four to eight pounds of lead, a highly toxic heavy metal.
E-waste should not be considered waste. It is a resource. Useful materials such as glass, copper, aluminum, plastic and other components can often be extracted and reused. Some manufacturers have even referred to e-waste as a valuable source of materials.
With an increasing array of environmentally-friendly options now available, people should consider recycling or donating their old electronic devices. With either choice, we can reduce the amount of e-waste and actually put our old items to good use.
More information about recycling electronics:
Content provided by Earth 911, the leading nationwide directory of local recycling resources.
Greeting the New Year
Setting Personal Goals
Many people enjoy ringing in the New Year and use it as a time for reflection and a time to look toward the future. However for many, it can be a difficult time as they are faced with challenges that impact their lives and uncertainties for the future.
As we look toward the year ahead, we have a tendency to set resolutions, to look at things we can do differently to better ourselves and/or others. For me, setting resolutions was something I would try to do annually but I was finding that most of the time they seemed to be the same ones. At one point I decided to create ‘rollover resolutions’…..why try to set more when in all actuality, they were just the same old ones said differently! Now I’m approaching this in another way, I have substituted resolutions with personal goals.
Read balance of Susan's Story - Click here - then scroll down on her page to find this story.
Come back to this page to leave any comments you may have...
|50 Ways to Keep Your Brain Healthy|
Research shows that the things you do every day can actually
exercise your brain. Our brain teasers range from
snacking on walnuts to ballroom dancing.
Check them out!
Click here to continue »
– Five Tools for Improving Your Memory
Reported by Trent S.-in Miami -- thanks Trent
Biotechnology companies Biogen Idec Inc. and Elan Corp. on Monday reported the fourth case this year of a deadly brain infection in a patient taking their multiple-sclerosis drug Tysabri.
The companies said they notified relevant regulatory agencies about the patient, located in the European Union, on Dec. 11. That patient has received about 26 months of Tysabri for the autoimmune condition multiple sclerosis and is being treated by a physician.
The drug has been facing pressure on the market since August, when the companies reported two new cases of the brain infection called progressive multifocal leukoencephalopathy, or PML. A third case was reported in November. More than 35,500 patients are taking the drug worldwide.
The companies have argued the risks, which are on the drug's label, are outweighed by the benefit the drug provides to multiple sclerosis patients. Tysabri was pulled from the market in 2005 after being linked to PML but reintroduced under restricted sales conditions in mid-2006.
Source: CNNMoney.com © 2008 Cable News Network.(15/12/08).
By Dermot Doherty and Naomi Kresge
Dec. 12 (Bloomberg) -- Novartis AG, Switzerland’s second- biggest drugmaker, said its experimental oral treatment FTY720 kept multiple sclerosis at bay in a study.
The medicine cut annualized relapse rates by 38 to 52 percent in the study, depending on the dose, compared with treatment with Biogen Idec Inc.’s interferon therapy Avonex, the Basel, Switzerland-based company said today.
The compound was “generally well-tolerated” and the side effects were in line with previous trials, Novartis said. Seven patients in the study were diagnosed with skin cancer in the FTY720 group, compared with one patient in the interferon group. All the skin cancers were successfully removed, the Swiss company said. Novartis already reported two fatal herpes infections in patients being treated with its drug, which suppresses the immune system.
“The safety profile of FTY720 has been a primary concern for investors, and over time more and more safety issues have shown up,” Tim Anderson, an analyst for Sanford C. Bernstein & Co., wrote in a note to investors. “It is important to realize, however, that all currently available MS drugs have significant side effects.”
Novartis fell as much as 3 percent to 53.5 Swiss francs in Swiss trading. The stock declined 60 centimes, or 1.1 percent, to 54.55 francs at 11:54 a.m.
The Swiss drugmaker said it will release full results at a major scientific conference in 2009. The company plans to ask regulators in Europe and the U.S. by the end of 2009 to approve FTY720, potentially the first oral pill for multiple sclerosis.
This holiday season, MS LifeLines® wants to remind you to take some time for yourself and relax!
Amidst the hustle and bustle of the season, it's important to try to schedule some downtime for yourself. Even finding twenty minutes in a day to unwind and relax can go a long way to relieving tension and recharging your batteries.
MS LifeLines Ambassador Teresa knows how important it is to relax. Whether it's crocheting, reading, doing crossword puzzles or watching her favorite television game show, Teresa knows that relaxing is an important part of her day that also delivers real health benefits. "I love doing word puzzles because they help me unwind and keep my mind sharp."
Relaxing can provide lots of health and wellness benefits, including helping you have better sleep, a decrease in tension and more energy. And there are many, many ways to relax. For instance, reading is a wonderful way to exercise your mind and escape from the day-to-day. If reading is difficult on your eyes, find books with larger print or books on tape or CD, all of which are available at most local libraries.
Research Ctr information found below the listing of:
CURRENT ENROLLMENT STUDIES:
Rationale: Multiple sclerosis occurs when the immune system mistakenly attacks nerve fiber-insulating myelin and other brain and spinal cord tissues. Laquinimod is believed to affect this attack. Oral laquinimod (Teva Pharmaceutical Industries) reduced disease activity by 40.4% compared with inactive placebo in a phase 2 study of 306 people with relapsing-remitting MS. (Lancet 2008; 371: 2085–92) A phase 3 study of laquinimod versus inactive placebo is currently underway in 1000 people with relapsing-remitting MS.
Dec 02, 2008
The year saw rapid research progress in virtually every field of science and medicine that impacts our understanding of the unpredictable neurological disease of multiple sclerosis. Thanks to its generous contributors, in 2008 the National MS Society invested nearly $50 million to support over 440 new and ongoing MS research projects as part of its international effort to prevent, treat and cure MS.
Significant advances have been made in both clinical and laboratory studies in MS. In addition, more than 130 clinical trials are underway around the world – with over one dozen final-phase trials of new therapies including some taken by mouth. Key highlights of the last year include:
To Read Balance of this article from the Nat'l MS Society, Click Here
|How Schwann Cells Might Be Altered So That They Might Be Better Candidates For Myelin Transplantation|
|Author: Anne Baron-Evercooren, PhD|
|Release Date: Wednesday 10-Dec-08 2:00 PM|
Dr. Anne Baron-Evercooren, Centre Hospitalier Universitaire, Pitié-Salpêtrière, Paris, presented her investigation of how Schwann cells might be altered so that they might be better candidates for myelin transplantation. By forcing the cells to express an enzyme, sialyltransferase, their ability to migrate was greatly improved. Schwann cells (SC) form myelin in the peripheral nerves and are easy to get. Despite their obvious repair potential in the central nervous system (CNS),... [More Info]
IF YOU Suffer from the MS Hug, please tell others what you do to manage this symptom.
|Info obtained from the MSIF.|
UK MS Society calls for law change on unproven stem cell trials
|Following the recent guidelines on unproven stem cell treatments by the International Society for Stem Cell Research (ISSCR), the UK MS Society is calling on the UK government to change the law on advertising medicines.|
The MS Society supports the advice from the ISSCR that patients and their families should approach stem cell therapy with caution. To read more click here.
» Read More Please Return to this page to Leave your Comments
|Timothy L. Vollmer, MD |
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center
|My Educational Video on MS and MS Trials|
Produced by www.MSNewsChannel.com
» Read More ( Come back to this page to leave your comments )
Multiple sclerosis can be an insidious disease, affecting many parts of the body and gradually causing serious disability. What is it like to live with MS? Eight men and women speak about their experiences.
Click this link to LISTEN to their stories.
Some 80,000 people in Germany suffer from multiple sclerosis – their immune system attacks and destroys healthy nerve tissue. Researchers at the Heidelberg University Hospital and the German Cancer Research Center in Heidelberg have succeeded in vaccinating mice with specially treated, autologous immune cells and preventing them from developing encephalitis, which is similar to multiple sclerosis in humans. A protein of the nervous system, that is the target of the harmful immune reaction in multiple sclerosis, was placed on the surface of the cells; the cells were treated with an agent that suppresses immune defense.
The Heidelberg researchers have published their results – initially online – in the prestigious journal "Proceedings of the National Academy of Sciences USA".
The team around Professor Dr. Peter Terness is working in the Department of Transplantation Immunology (Director: Professor Dr. Gerhard Opelz) of the Institute of Immunology at the Heidelberg University Hospital. Professor Terness and his colleagues work primarily on developing methods to prevent rejection of donor organs without impairing the immune system.Above found at Eureka Alerts on Nov 28, 2008
Cognitive Dysfunction Tips
For people with cognitive dysfunction as a symptom of multiple sclerosis (MS), seemingly simple tasks can be frustrating. Try some of these tips and ideas for helping yourself avoid stress and get things done.
Info found above is from about.com and will direct you to their website, providing you with another excellent source for information..
The MS LifeLines® Peer Connection Program
If you are new to Rebif® (interferon beta-1a) therapy or considering Rebif for your relapsing MS, it may help to talk to someone who understands. Now, with the MS LifeLines® Peer Connection Program, you can. Learn how to connect.
3 easy steps to connect
Support Every Step of the Way
Join the MS LifeLines Community
MS LifeLines is a free support service designed to help you start and stay on Rebif therapy today and every step of the way. Our mission is to offer connections, understanding, and support to people on or considering Rebif, and the family and friends who care for them.
Tis’ the season to be jolly….overwhelmed and exhausted! Yes, it’s that time again, already! I am surprised every year how quickly the time has gone by and what little time there is to get ready for the holidays. There is so much we need to think about: gifts, attending parties, entertaining, visitors, decorating, and so much more.
I thought a great place to start would be shopping for gifts. This is something I do all year long, let me explain. When I see something that makes me think of someone in particular, I buy it. Then I put it away and save it for their gift (ok, sometimes the timing may fall in time for the birthday but that’s ok, at least that’s taken care of). I make a list, especially if I’ve already bought something, so I can remember what I have and what I still need. CLICK HERE to continue reading this well prepared article..